Workflow
顺腾国际控股(00932) - 2025 - 中期业绩
SHUNTEN INTLSHUNTEN INTL(HK:00932)2024-11-28 10:45

Financial Performance - For the six months ended September 30, 2024, the company reported revenue of HKD 102,996,000, a decrease of 19.5% compared to HKD 128,012,000 for the same period in 2023[3] - The adjusted net profit for the period was HKD 2,739,000, down 81.5% from HKD 14,746,000 in the previous year[3] - The company incurred a loss attributable to owners of HKD 4,261,000, compared to a profit of HKD 10,846,000 in the same period last year[3] - The company reported a pre-tax loss of HKD 2,893,000 for the six months ended September 30, 2024, compared to a pre-tax profit of HKD 13,556,000 for the same period in 2023[23][28] - The company recorded a loss attributable to shareholders of approximately HKD 4.3 million, compared to a profit of approximately HKD 10.8 million in the same period last year[45] - Total revenue for the period was HKD 103 million, a decrease of approximately 19.5% from HKD 128 million in the previous year[55] Revenue Breakdown - The segment revenue from health and beauty products was HKD 100,191,000, while property investment revenue was HKD 2,805,000 for the six months ended September 30, 2024[26] - The revenue from health and beauty supplements decreased by approximately 20.5% to about HKD 100.2 million, down from HKD 126 million in the same period last year[57] - Revenue from property investment increased by approximately 40.0% to about HKD 2.8 million, compared to HKD 2 million in the previous year[57] Cost and Expenses - The cost of sales decreased by approximately 21.8% to about HKD 23.3 million, with a gross margin slightly increasing to about 77.3%[58] - Selling and distribution expenses decreased by approximately 13.7% to about HKD 22.6 million, due to cost control measures and reduced sales commissions[59] - Administrative expenses decreased by approximately 2.5% to about HKD 49.8 million, primarily due to reduced rent for designated counters[60] - The company's employee costs decreased to HKD 36.07 million from HKD 38.27 million, a reduction of about 5.7%[32] - The company’s inventory costs decreased to HKD 16.9 million from HKD 22.48 million, a decline of approximately 25.0%[32] Assets and Liabilities - Total assets decreased to HKD 248,210,000 from HKD 258,379,000 as of March 31, 2024[12] - The company’s accounts receivable as of September 30, 2024, was approximately HKD 25.83 million, down from HKD 27.65 million as of March 31, 2024[40] - The company’s accounts payable as of September 30, 2024, was approximately HKD 1.84 million, a decrease from HKD 2.36 million as of March 31, 2024[42] - The total liabilities as of September 30, 2024, were HKD 164,303,000, a decrease from HKD 172,726,000 as of March 31, 2024, reflecting a reduction of about 4.9%[30] - The net current liabilities improved to HKD (73,745,000) from HKD (79,545,000) year-on-year[12] Cash Flow and Liquidity - The company's cash and cash equivalents increased to HKD 18,704,000 from HKD 12,700,000[12] - As of September 30, 2024, the cash and bank balance was approximately HKD 18.7 million, up from HKD 12.7 million as of March 31, 2024[66] - Current liabilities decreased to HKD 157,240,000 from HKD 165,500,000, indicating improved liquidity[12] Strategic Initiatives - The company launched a customer relationship management mobile app "御賞會" to enhance customer engagement and marketing strategies[52] - The company is expanding sales channels by opening flagship stores on Tmall and Douyin to enter the mainland China market[50] - The group plans to actively explore new revenue sources and expand sales channels to enhance market share in the health and beauty supplement sector[78] - The group aims to leverage cross-border e-commerce platforms to reach mainland Chinese customers, utilizing social media and key opinion leaders for product promotion[78] Future Outlook - The company continues to adopt the going concern basis in preparing its financial statements, indicating confidence in its operational sustainability in the foreseeable future[1] - The company will continue to monitor market conditions and implement appropriate strategies to optimize overall performance[46] Dividend Policy - The company did not recommend the payment of an interim dividend for the two interim periods[36] - The board does not recommend declaring an interim dividend for the reporting period, consistent with the previous year[77] Other Information - The company applied several amendments to the Hong Kong Financial Reporting Standards, which did not significantly impact the financial position or performance for the current and prior periods[18] - There were no significant acquisitions or disposals of subsidiaries, associates, or joint ventures during the reporting period[71] - The overall capital management strategy remains unchanged, focusing on optimizing debt and equity balance to maximize shareholder returns[69] - The group has no significant contingent liabilities as of September 30, 2024, consistent with the previous reporting period[75]